[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352437-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352437-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","global-research-trends-and-focus-on-biomarkers-in-lung-cancer-immunotherapy-comprehensive-bibliometric-insight-and-visualization-analysis","Global research trends and focus on biomarkers in lung cancer immunotherapy - comprehensive bibliometric insight and visualization analysis","","Global research trends and focus on biomarkers in lung cancer immunotherapy are mapped using bibliometric methods to address rapid growth and knowledge fragmentation in predictive biomarker discovery. A total of 6,180 publications from 2001–2025 in the Web of Science Core Collection were analyzed with Bibliometrix, VOSviewer, and CiteSpace to assess publication patterns, country and institutional contributions, journal and author networks, keyword evolution, and citation dynamics. Growth, hotspot emergence, and future directions are synthesized to support multidimensional integration.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/global-research-trends-and-focus-on-biomarkers-in-lung-cancer-immunotherapy-comprehensive-bibliometric-insight-and-visualization-analysis/352437/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/global-research-trends-and-focus-on-biomarkers-in-lung-cancer-immunotherapy-comprehensive-bibliometric-insight-and-visualization-analysis/352437.png","ImageObject",300,407,{"name":42,"@type":43},"Theodore","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main goal of this bibliometric study?","Question",{"text":63,"@type":64},"To synthesize global research achievements, trace the evolution of immunotherapy biomarkers in lung cancer, identify research hotspots, and forecast development trends.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were publications and trends analyzed?",{"text":68,"@type":64},"The study analyzed 6,180 Web of Science Core Collection publications (2001–2025) using Bibliometrix, VOSviewer, and CiteSpace, covering publication trends, collaborations, keyword changes, and citation dynamics.",{"name":70,"@type":61,"acceptedAnswer":71},"What phases and growth pattern were observed in the field?",{"text":72,"@type":64},"The research progressed through incubation (2003–2014), rapid expansion (2015–2022), and maturation (2023–2025), with a reported 28.87% annual growth rate.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352437,1790473192,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":118,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":104,"preview_page_count":33,"preview_urls":145},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","TYPE Systematic Review PUBLISHED 03 February 2026 DOI 10.3389/fimmu.2026.1622573  \nOPEN ACCESS  \nEDITED BY  \nPeter Brossart,  \nUniversity of Bonn, Germany  \nREVIEWED BY  \nMaria Vitale,  \nDipartimento di Medicina Molecolare e Biotecnologie Mediche, Italy  \nPeter Kokol,  \nUniversity of Maribor, Slovenia  \n*CORRESPONDENCE  \nChaoyuan Liu  \n [lcyyyxx@csu.edu.cn](lcyyyxx@csu.edu.cn)[ ](lcyyyxx@csu.edu.cn)Xianling Liu  \n [liuxianling@csu.edu.cn](liuxianling@csu.edu.cn)  \nRECEIVED 03 May 2025  \nREVISED 16 December 2025  \nACCEPTED 19 January 2026  \nPUBLISHED 03 February 2026  \nCITATION  \nHe J, Liu C, Ma F, Zhou Y and Liu X (2026) Global research trends and focus on biomarkers in lung cancer immunotherapy: a comprehensive bibliometric insight and visualization analysis (2001-2025) .  \nFront. Immunol. 17:1622573 .  \ndoi: 10.3389/fimmu.2026.1622573  \nCOPYRIGHT  \n© 2026 He, Liu, Ma, Zhou and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nGlobal research trends and focus on biomarkers in lung cancer immunotherapy: a comprehensive bibliometric insight and visualization analysis (2001-2025)  \nJiangbo He 1, Chaoyuan Liu 1*, Fang Ma 1, Yiguang Zhou 1 and Xianling Liu 1,2*  \n1 Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China, 2 Department of Oncology, Guilin Hospital of the Second Xiangya Hospital, Central South University, Guilin, China  \nBackground: Immunotherapy has revolutionized the therapeutic paradigm for lung cancer, yet its clinical efﬁcacy exhibits signiﬁcant interpatient heterogeneity. The implementation of personalized immunotherapy critically depends on the precise identiﬁcation of predictive biomarkers. However, this ﬁeld is currently characterized by rapid expansion of research outputs alongside marked fragmentation of knowledge domains, while a systematic evaluation ofscientiﬁc advancements and emerging frontiers remains conspicuously absent. This study aims to synthesize global research achievements to methodologically delineate the evolutionary trajectory of immunotherapy biomarkers in lung cancer, identify research hotspots, and forecast developmental trends. Methods: A bibliometric analysis was conducted on 6,180 publications (2001– 2025) from the Web of Science Core Collection. Advanced tools (Bibliometrix, VOSviewer, CiteSpace) were employed to analyze publication trends, country/ institutional contributions, journal inﬂuence, author networks, keyword evolution, and citation dynamics.  \nResults: The ﬁeld progressed through incubation (2003–2014), rapid expansion (2015–2022), and maturation (2023–2025) phases, with a 28.87% annual growth rate. China led in productivity (9,394 publications), while the U. S. dominated academic impact (93,888 citations) . Harvard University Harvard University emerged as the predominant contributor (532 publications) . WANG Y was ranked ﬁrst in the top 10 most proliﬁc authors (97 publications) while RAMALINGAM SS (5,033 citations) was the most cited authors. CANCERS (319 papers; Q1) was the most published journal, while JOURNAL FOR IMMUNOTHERAPY OF CANCER (8,511 citations; Q1) was the most cited journal. Emerging frontiers encompassed genomics, gut microbiome, soluble PD-L1, and immune inﬁltration patterns, driven by multi-omics integration andartiﬁcial intelligence.  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nConclusion: This study represents the ﬁrst bibliometric analysis of biomarkers in lung cancer immunotherapy. Through scientometric visualization tools, our analysis delineates a paradigm shift from reductionist bi","cbCaiqbdcs8NfFom","https://ap.wps.com/l/cbCaiqbdcs8NfFom","pdf",24784211,"English","# Background\n## Personalized immunotherapy and biomarker need\n# Methods\n## Bibliometric data source and tools\n# Results\n## Growth phases and global contributions\n## Journals, authors, and emerging frontiers\n# Conclusion\n## Shift toward multidimensional integration","[{\"question\":\"What is the main goal of this bibliometric study?\",\"answer\":\"To synthesize global research achievements, trace the evolution of immunotherapy biomarkers in lung cancer, identify research hotspots, and forecast development trends.\"},{\"question\":\"How were publications and trends analyzed?\",\"answer\":\"The study analyzed 6,180 Web of Science Core Collection publications (2001–2025) using Bibliometrix, VOSviewer, and CiteSpace, covering publication trends, collaborations, keyword changes, and citation dynamics.\"},{\"question\":\"What phases and growth pattern were observed in the field?\",\"answer\":\"The research progressed through incubation (2003–2014), rapid expansion (2015–2022), and maturation (2023–2025), with a reported 28.87% annual growth rate.\"}]","Global research trends and focus on biomarkers in lung cancer immunotherapy - comprehensive bibliometric insight and visualization analysis | PDF",1790099631,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/69caf964c3aebfef28810e71e4ade170.webp",983,1389,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b5d1d2de2aa42d1d10882a75c7325d9f.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8e13036e0b029b893babae38598e0f4b.webp",981,1386,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9324a5f4e61addfb5b4bf55749265395.webp",980,1385]